Profile data is unavailable for this security.
About the company
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.
- Revenue in USD (TTM)47.70bn
- Net income in USD6.43bn
- LocationMerck & Co Inc2000 Galloping Hill RdKENILWORTH 07033-1310United StatesUSA
- Phone+1 (908) 740-4000
- Fax+1 (908) 423-1987
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|MRK:NYQ since |
|Acceleron Pharma Inc||Deal completed||30 Sep 2021||30 Sep 2021Deal completed||7.31%||11.59bn|
|Pandion Therapeutics Inc||Deal completed||25 Feb 2021||25 Feb 2021Deal completed||8.06%||1.81bn|